Trevi Therapeutics Inc (NASDAQ:TRVI)
| 1.15 Delayed Data As of 3:59pm ET |  -0.005 / -0.43%Today’s Change | 0.97 Today|||52-Week Range 3.50 | -40.67% Year-to-Date |
Latest TRVI News | Press Releases
| Down -38.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Trevi Therapeutics, Inc. (TRVI) Nov 30 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.15 |
| Today’s open | 1.17 |
| Day’s range | 1.10 - 1.19 |
| Volume | 72,725 |
| Average volume (3 months) | 242,043 |
| Market cap | $73.4M |
Data as of 3:59pm ET, 12/11/2023
Growth & Valuation
| Earnings growth (last year) | +69.60% |
| Earnings growth (this year) | +20.74% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.65 |
Competitors
Data as of 3:59pm ET, 12/11/2023
Financials
| Next reporting date | March 20, 2024 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$29.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New Haven, Connecticut |
Forecasts
